{"count": 15, "results": [{"_id": "35713426", "pmid": 35713426, "pmcid": "PMC9276215", "title": "The role of statins in patients with early diabetic nephropathy", "journal": "Medicine (Baltimore)", "authors": ["Zhao X", "Zhou SC", "Wang XF", "Liao HW"], "date": "2022-06-17T00:00:00Z", "doi": "10.1097/MD.0000000000029099", "meta_date_publication": "2022 Jun 17", "meta_volume": "101", "meta_issue": "24", "meta_pages": "e29099", "score": 50259.844, "text_hl": "The role of statins in @SPECIES_9606 @@@patients@@@ with early @<m>DISEASE_Diabetic_Nephropathies</m> @DISEASE_MESH:D003928 @@@diabetic nephropathy@@@", "citations": {"NLM": "Zhao X, Zhou SC, Wang XF, Liao HW. The role of statins in patients with early diabetic nephropathy Medicine (Baltimore). 2022 Jun 17;101(24):e29099. PMID: 35713426", "BibTeX": "@article{35713426, title={The role of statins in patients with early diabetic nephropathy}, author={Zhao X and Zhou SC and Wang XF and Liao HW}, journal={Medicine (Baltimore)}, volume={101}, number={24}, pages={e29099}}"}}, {"_id": "38278349", "pmid": 38278349, "title": "Simvastatin mitigates diabetic nephropathy by upregulating farnesoid X receptor and Nrf2/HO-1 signaling and attenuating oxidative stress and inflammation in rats.", "journal": "Life Sci", "authors": ["Hasan IH", "Shaheen SY", "Alhusaini AM", "Mahmoud AM"], "date": "2024-03-01T00:00:00Z", "doi": "10.1016/j.lfs.2024.122445", "meta_date_publication": "2024 Mar 1", "meta_volume": "340", "meta_issue": "", "meta_pages": "122445", "score": 50259.375, "text_hl": "The @CHEMICAL_Cholesterol @CHEMICAL_MESH:D002784 @@@cholesterol@@@-lowering drug @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SIM@@@) has shown promising effects against @<m>DISEASE_Diabetic_Nephropathies</m> @DISEASE_MESH:D003928 @@@diabetic nephropathy@@@ (@<m>DISEASE_Diabetic_Nephropathies</m> @DISEASE_MESH:D003928 @@@DN@@@). ", "citations": {"NLM": "Hasan IH, Shaheen SY, Alhusaini AM, Mahmoud AM. Simvastatin mitigates diabetic nephropathy by upregulating farnesoid X receptor and Nrf2/HO-1 signaling and attenuating oxidative stress and inflammation in rats. Life Sci. 2024 Mar 1;340():122445. PMID: 38278349", "BibTeX": "@article{38278349, title={Simvastatin mitigates diabetic nephropathy by upregulating farnesoid X receptor and Nrf2/HO-1 signaling and attenuating oxidative stress and inflammation in rats.}, author={Hasan IH and Shaheen SY and Alhusaini AM and Mahmoud AM}, journal={Life Sci}, volume={340}, pages={122445}}"}}, {"_id": "35128870", "pmid": 35128870, "title": "[Effect of electroacupuncture of \"Biao-Ben\" acupoints on renal function and hemorheology and eNOS level in patients with early diabetic nephropathy].", "journal": "Zhen Ci Yan Jiu", "authors": ["Wang KX", "Liang FX", "Chen S", "Luo ZH", "Chen B", "Chen ZQ", "Zhang YL", "Chen J", "Gu XL", "Zhou T", "Yan P", "Xu XY"], "date": "2022-01-25T00:00:00Z", "doi": "10.13702/j.1000-0607.20210036", "meta_date_publication": "2022 Jan 25", "meta_volume": "47", "meta_issue": "1", "meta_pages": "46-52", "score": 50241.32, "text_hl": "OBJECTIVE: To observe the effect of electroacupuncture (EA) of \"Biao-Ben acupoints\" (Biao indicates pathogenic factors of disease; Ben refers to body constitution) on renal function, hemorheology and @GENE_NOS3 @GENE_4846 @@@endothelial nitric oxide synthase@@@ (@GENE_NOS3 @GENE_4846 @@@eNOS@@@) level in @SPECIES_9606 @@@patients@@@ with early @<m>DISEASE_Diabetic_Nephropathies</m> @DISEASE_MESH:D003928 @@@diabetic kidney disease@@@ (@<m>DISEASE_Diabetic_Nephropathies</m> @DISEASE_MESH:D003928 @@@DKD@@@), so as to explore its mechanism underlying relieving early @<m>DISEASE_Diabetic_Nephropathies</m> @DISEASE_MESH:D003928 @@@DKD@@@. ", "citations": {"NLM": "Wang KX, Liang FX, Chen S, Luo ZH, Chen B, Chen ZQ, Zhang YL, Chen J, Gu XL, Zhou T, Yan P, Xu XY. [Effect of electroacupuncture of \"Biao-Ben\" acupoints on renal function and hemorheology and eNOS level in patients with early diabetic nephropathy]. Zhen Ci Yan Jiu. 2022 Jan 25;47(1):46-52. PMID: 35128870", "BibTeX": "@article{35128870, title={[Effect of electroacupuncture of \"Biao-Ben\" acupoints on renal function and hemorheology and eNOS level in patients with early diabetic nephropathy].}, author={Wang KX and Liang FX and Chen S and Luo ZH and Chen B and Chen ZQ and Zhang YL and Chen J and Gu XL and Zhou T and Yan P and Xu XY}, journal={Zhen Ci Yan Jiu}, volume={47}, number={1}, pages={46-52}}"}}, {"_id": "1521727", "pmid": 1521727, "title": "Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy.", "journal": "Diabetologia", "authors": ["Hommel E", "Andersen P", "Gall MA", "Nielsen F", "Jensen B", "Rossing P", "Dyerberg J", "Parving HH"], "date": "1992-05-01T00:00:00Z", "doi": "10.1007/BF02342442", "meta_date_publication": "1992 May", "meta_volume": "35", "meta_issue": "5", "meta_pages": "447-51", "score": 50077.133, "text_hl": "Plasma lipoproteins and renal function during @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ treatment in @<m>DISEASE_Diabetic_Nephropathies</m> @DISEASE_MESH:D003928 @@@diabetic nephropathy@@@.", "citations": {"NLM": "Hommel E, Andersen P, Gall MA, Nielsen F, Jensen B, Rossing P, Dyerberg J, Parving HH. Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy. Diabetologia. 1992 May;35(5):447-51. PMID: 1521727", "BibTeX": "@article{1521727, title={Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy.}, author={Hommel E and Andersen P and Gall MA and Nielsen F and Jensen B and Rossing P and Dyerberg J and Parving HH}, journal={Diabetologia}, volume={35}, number={5}, pages={447-51}}"}}, {"_id": "24244596", "pmid": 24244596, "pmcid": "PMC3828237", "title": "Simvastatin Alleviates Hyperpermeability of Glomerular Endothelial Cells in Early-Stage Diabetic Nephropathy by Inhibition of RhoA/ROCK1", "journal": "PLoS One", "authors": ["Peng H", "Luo P", "Li Y", "Wang C", "Liu X", "Ye Z", "Li C", "Lou T"], "date": "2013-11-14T00:00:00Z", "doi": "10.1371/journal.pone.0080009", "meta_date_publication": "2013", "meta_volume": "8", "meta_issue": "11", "meta_pages": "e80009", "score": 50062.87, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ Alleviates Hyperpermeability of Glomerular Endothelial Cells in Early-Stage @<m>DISEASE_Diabetic_Nephropathies</m> @DISEASE_MESH:D003928 @@@Diabetic Nephropathy@@@ by Inhibition of @GENE_RHOA @GENE_11848 @@@RhoA@@@/ROCK1", "citations": {"NLM": "Peng H, Luo P, Li Y, Wang C, Liu X, Ye Z, Li C, Lou T. Simvastatin Alleviates Hyperpermeability of Glomerular Endothelial Cells in Early-Stage Diabetic Nephropathy by Inhibition of RhoA/ROCK1 PLoS One. 2013;8(11):e80009. PMID: 24244596", "BibTeX": "@article{24244596, title={Simvastatin Alleviates Hyperpermeability of Glomerular Endothelial Cells in Early-Stage Diabetic Nephropathy by Inhibition of RhoA/ROCK1}, author={Peng H and Luo P and Li Y and Wang C and Liu X and Ye Z and Li C and Lou T}, journal={PLoS One}, volume={8}, number={11}, pages={e80009}}"}}, {"_id": "19639539", "pmid": 19639539, "title": "Rhein improves renal lesion and ameliorates dyslipidemia in db/db mice with diabetic nephropathy.", "journal": "Planta Med", "authors": ["Gao Q", "Qin WS", "Jia ZH", "Zheng JM", "Zeng CH", "Li LS", "Liu ZH"], "date": "2010-01-01T00:00:00Z", "doi": "10.1055/s-0029-1185948", "meta_date_publication": "2010 Jan", "meta_volume": "76", "meta_issue": "1", "meta_pages": "27-33", "score": 50061.797, "text_hl": "Rhein is a new drug that can decrease @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ levels and protect against @<m>DISEASE_Diabetic_Nephropathies</m> @DISEASE_MESH:D003928 @@@DN@@@ progression in a different fashion with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@.", "citations": {"NLM": "Gao Q, Qin WS, Jia ZH, Zheng JM, Zeng CH, Li LS, Liu ZH. Rhein improves renal lesion and ameliorates dyslipidemia in db/db mice with diabetic nephropathy. Planta Med. 2010 Jan;76(1):27-33. PMID: 19639539", "BibTeX": "@article{19639539, title={Rhein improves renal lesion and ameliorates dyslipidemia in db/db mice with diabetic nephropathy.}, author={Gao Q and Qin WS and Jia ZH and Zheng JM and Zeng CH and Li LS and Liu ZH}, journal={Planta Med}, volume={76}, number={1}, pages={27-33}}"}}, {"_id": "20936727", "pmid": 20936727, "title": "[Effects of simvastatin on expression of CTGF and alpha-SMA in renal tubulointerstitium of rats with diabetic nephropathy].", "journal": "Zhejiang Da Xue Xue Bao Yi Xue Ban", "authors": ["Lin FL", "Shen HC", "Zhu B", "Lin KQ"], "date": "2010-09-01T00:00:00Z", "doi": "10.3785/j.issn.1008-9292.2010.05.012", "meta_date_publication": "2010 Sep", "meta_volume": "39", "meta_issue": "5", "meta_pages": "511-6", "score": 50060.926, "text_hl": "[Effects of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on expression of @GENE_CCN2 @GENE_64032 @@@CTGF@@@ and alpha-SMA in @DISEASE_Glycosuria_Renal @DISEASE_MESH:D006030 @@@renal tubulointerstitium@@@ of @SPECIES_10116 @@@rats@@@ with @<m>DISEASE_Diabetic_Nephropathies</m> @DISEASE_MESH:D003928 @@@diabetic nephropathy@@@].", "citations": {"NLM": "Lin FL, Shen HC, Zhu B, Lin KQ. [Effects of simvastatin on expression of CTGF and alpha-SMA in renal tubulointerstitium of rats with diabetic nephropathy]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2010 Sep;39(5):511-6. PMID: 20936727", "BibTeX": "@article{20936727, title={[Effects of simvastatin on expression of CTGF and alpha-SMA in renal tubulointerstitium of rats with diabetic nephropathy].}, author={Lin FL and Shen HC and Zhu B and Lin KQ}, journal={Zhejiang Da Xue Xue Bao Yi Xue Ban}, volume={39}, number={5}, pages={511-6}}"}}, {"_id": "29860221", "pmid": 29860221, "title": "Simvastatin ameliorates diabetic nephropathy by attenuating oxidative stress and apoptosis in a rat model of streptozotocin-induced type 1 diabetes.", "journal": "Biomed Pharmacother", "authors": ["Al-Rasheed NM", "Al-Rasheed NM", "Bassiouni YA", "Hasan IH", "Al-Amin MA", "Al-Ajmi HN", "Mahmoud AM"], "date": "2018-09-01T00:00:00Z", "doi": "10.1016/j.biopha.2018.05.130", "meta_date_publication": "2018 Sep", "meta_volume": "105", "meta_issue": "", "meta_pages": "290-298", "score": 50059.617, "text_hl": "The present study investigates the ameliorative effect of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SIM@@@) on @<m>DISEASE_Diabetic_Nephropathies</m> @DISEASE_MESH:D003928 @@@diabetic nephropathy@@@ in @SPECIES_10116 @@@rats@@@, pointing to its anti-apoptotic and anti-oxidative stress efficacies. ", "citations": {"NLM": "Al-Rasheed NM, Al-Rasheed NM, Bassiouni YA, Hasan IH, Al-Amin MA, Al-Ajmi HN, Mahmoud AM. Simvastatin ameliorates diabetic nephropathy by attenuating oxidative stress and apoptosis in a rat model of streptozotocin-induced type 1 diabetes. Biomed Pharmacother. 2018 Sep;105():290-298. PMID: 29860221", "BibTeX": "@article{29860221, title={Simvastatin ameliorates diabetic nephropathy by attenuating oxidative stress and apoptosis in a rat model of streptozotocin-induced type 1 diabetes.}, author={Al-Rasheed NM and Al-Rasheed NM and Bassiouni YA and Hasan IH and Al-Amin MA and Al-Ajmi HN and Mahmoud AM}, journal={Biomed Pharmacother}, volume={105}, pages={290-298}}"}}, {"_id": "18083785", "pmid": 18083785, "title": "Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control.", "journal": "Diabetes", "authors": ["Kolavennu V", "Zeng L", "Peng H", "Wang Y", "Danesh FR"], "date": "2008-03-01T00:00:00Z", "doi": "10.2337/db07-1241", "meta_date_publication": "2008 Mar", "meta_volume": "57", "meta_issue": "3", "meta_pages": "714-23", "score": 50057.598, "text_hl": "In the current study, we hypothesized that pharmacological blockade of the @GENE_RHOA @GENE_11848 @@@RhoA@@@/ROCK pathway with either @CHEMICAL_fasudil @CHEMICAL_MESH:C049347 @@@fasudil@@@ or @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ would ameliorate progression of @<m>DISEASE_Diabetic_Nephropathies</m> @DISEASE_MESH:D003928 @@@diabetic nephropathy@@@. ", "citations": {"NLM": "Kolavennu V, Zeng L, Peng H, Wang Y, Danesh FR. Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control. Diabetes. 2008 Mar;57(3):714-23. PMID: 18083785", "BibTeX": "@article{18083785, title={Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control.}, author={Kolavennu V and Zeng L and Peng H and Wang Y and Danesh FR}, journal={Diabetes}, volume={57}, number={3}, pages={714-23}}"}}, {"_id": "19839828", "pmid": 19839828, "title": "Simvastatin reverses podocyte injury but not mesangial expansion in early stage type 2 diabetes mellitus.", "journal": "Ren Fail", "authors": ["Wei P", "Grimm PR", "Settles DC", "Balwanz CR", "Padanilam BJ", "Sansom SC"], "date": "2009-01-01T00:00:00Z", "doi": "10.1080/08860220902963848", "meta_date_publication": "2009", "meta_volume": "31", "meta_issue": "6", "meta_pages": "503-13", "score": 50056.883, "text_hl": "Statins may confer renal protection in a variety of @DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@glomerular diseases@@@, including @<m>DISEASE_Diabetic_Nephropathies</m> @DISEASE_MESH:D003928 @@@diabetic nephropathy@@@ (@<m>DISEASE_Diabetic_Nephropathies</m> @DISEASE_MESH:D003928 @@@DN@@@). ", "citations": {"NLM": "Wei P, Grimm PR, Settles DC, Balwanz CR, Padanilam BJ, Sansom SC. Simvastatin reverses podocyte injury but not mesangial expansion in early stage type 2 diabetes mellitus. Ren Fail. 2009;31(6):503-13. PMID: 19839828", "BibTeX": "@article{19839828, title={Simvastatin reverses podocyte injury but not mesangial expansion in early stage type 2 diabetes mellitus.}, author={Wei P and Grimm PR and Settles DC and Balwanz CR and Padanilam BJ and Sansom SC}, journal={Ren Fail}, volume={31}, number={6}, pages={503-13}}"}}]}